HK1244674A1 - 一種包含含有鹽酸坦索羅辛的緩釋顆粒的口服藥物製劑 - Google Patents

一種包含含有鹽酸坦索羅辛的緩釋顆粒的口服藥物製劑

Info

Publication number
HK1244674A1
HK1244674A1 HK18103992.2A HK18103992A HK1244674A1 HK 1244674 A1 HK1244674 A1 HK 1244674A1 HK 18103992 A HK18103992 A HK 18103992A HK 1244674 A1 HK1244674 A1 HK 1244674A1
Authority
HK
Hong Kong
Prior art keywords
sustained
pharmaceutical formulation
oral pharmaceutical
granules containing
release granules
Prior art date
Application number
HK18103992.2A
Other languages
English (en)
Inventor
金炯序
崔榮根
趙正賢
金唇哲
金用鎰
朴宰賢
禹鐘守
Original Assignee
韓美藥品株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 韓美藥品株式會社 filed Critical 韓美藥品株式會社
Publication of HK1244674A1 publication Critical patent/HK1244674A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
HK18103992.2A 2015-02-16 2018-03-22 一種包含含有鹽酸坦索羅辛的緩釋顆粒的口服藥物製劑 HK1244674A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150023152A KR20160100570A (ko) 2015-02-16 2015-02-16 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제
PCT/KR2016/001538 WO2016133333A2 (en) 2015-02-16 2016-02-16 An oral pharmaceutical formulation comprising sustained-release granules containing tamsulosin hydrochloride

Publications (1)

Publication Number Publication Date
HK1244674A1 true HK1244674A1 (zh) 2018-08-17

Family

ID=56692410

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18103992.2A HK1244674A1 (zh) 2015-02-16 2018-03-22 一種包含含有鹽酸坦索羅辛的緩釋顆粒的口服藥物製劑

Country Status (13)

Country Link
US (1) US20180235913A1 (zh)
EP (1) EP3242654A4 (zh)
JP (1) JP2018508501A (zh)
KR (1) KR20160100570A (zh)
CN (1) CN107249569A (zh)
AU (1) AU2016220638A1 (zh)
BR (1) BR112017017385A2 (zh)
EA (1) EA201791523A1 (zh)
HK (1) HK1244674A1 (zh)
MX (1) MX2017010521A (zh)
PH (1) PH12017501466A1 (zh)
WO (1) WO2016133333A2 (zh)
ZA (1) ZA201705811B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3485877A4 (en) * 2016-07-15 2020-02-26 Hanmi Pharm. Co., Ltd. EXTENDED RELEASE GRANULE WITH TAMSULOSINE HYDROCHLORIDE.
AU2017308461A1 (en) * 2016-08-12 2019-02-28 Hanmi Pharm. Co., Ltd. Pharmaceutical preparation for oral administration with controlled dissolution rate, the preparation comprising tamsulosin hydrochloride-containing sustained-release pellets

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930007245A (ko) 1991-09-16 1993-04-22 강진구 영상신호 수신 장치
KR100582350B1 (ko) * 2004-02-17 2006-05-22 한미약품 주식회사 탐수로신 염산염의 경구투여용 조성물 및 이의 서방성과립 제제
KR20050114921A (ko) * 2004-06-02 2005-12-07 씨제이 주식회사 방출제어형 약제학적 조성물
KR20070021806A (ko) * 2005-08-19 2007-02-23 (주)아모레퍼시픽 α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법
KR20070044911A (ko) * 2005-10-26 2007-05-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
WO2007131804A1 (en) * 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
CN101204387A (zh) * 2006-12-19 2008-06-25 北京德众万全药物技术开发有限公司 一种盐酸坦洛新缓释胶囊
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
KR101423237B1 (ko) * 2010-05-04 2014-07-30 주식회사 삼양바이오팜 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
CN105338970B (zh) * 2013-06-28 2019-07-09 韩美药品株式会社 包含他达拉非和坦洛新的药物胶囊复合制剂

Also Published As

Publication number Publication date
EP3242654A2 (en) 2017-11-15
WO2016133333A2 (en) 2016-08-25
PH12017501466A1 (en) 2018-01-29
JP2018508501A (ja) 2018-03-29
BR112017017385A2 (pt) 2018-04-03
WO2016133333A3 (en) 2016-10-13
KR20160100570A (ko) 2016-08-24
AU2016220638A1 (en) 2017-08-17
EA201791523A1 (ru) 2017-12-29
EP3242654A4 (en) 2018-09-19
MX2017010521A (es) 2017-11-13
US20180235913A1 (en) 2018-08-23
CN107249569A (zh) 2017-10-13
ZA201705811B (en) 2019-02-27

Similar Documents

Publication Publication Date Title
GB201807942D0 (en) Pharmaceutical formulation
IL271226A (en) medical preparation
PT3426294T (pt) Formulação farmacêutica compreendendo anticorpo, ciclodextrina e metionina
HK1246641A1 (zh) 緩釋性醫藥組合物
IL262204A (en) Granular formulation for oral administration
ZA202102871B (en) Pharmaceutical formulation
IL266537A (en) pharmaceutical preparation
IL278927A (en) pharmaceutical preparation
HK1245653A1 (zh) 藥物製劑
IL253177B (en) Pharmacy preparation
ZA201807851B (en) Pharmaceutical formulation
LT3601277T (lt) Farmacinė vaisto forma
HK1244674A1 (zh) 一種包含含有鹽酸坦索羅辛的緩釋顆粒的口服藥物製劑
GB201506755D0 (en) Novel pharmaceutical formulation
SI3290023T1 (sl) Farmacevtski sestavek z zadržanim sproščanjem, ki vsebuje rivastigmin
IL275144A (en) Pharmacy preparation
GB201511246D0 (en) Pharmaceutical formulation
GB201719873D0 (en) Pharmaceutical formulation
GB201604545D0 (en) Novel pharmaceutical formulation
PT3453388T (pt) Solução farmacêutica compreendendo cloridrato de dopamina